Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.91 USD | +1.09% | +3.10% | -3.56% |
May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SUPERNUS PHARMACEUTICALS, INC. | Specialty & Advanced Pharmaceuticals | +1.09% | +3.10% | -3.56% | -16.76% | -10.46% | 1.52B |
- Stock Market
- Equities
- SUPN Stock
- Charts Supernus Pharmaceuticals, Inc.
- Relative Strength Chart